CFB and melanoma: Anti-tumor activity of Bf-CATH was also investigated, showing potent in vitro activity against mouse melanoma cells (IC50 ~7 μM) and in vivo inhibition of mouse melanoma cell proliferation, migration, and angiogenesis, but with a negligible effect against human tumoral cell lines (IC50s from ~20–100 μM).